Solid Biosciences (SLDB) Revenue (2022 - 2024)
Historic Revenue for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to -$75000.0.
- Solid Biosciences' Revenue changed N/A to -$75000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$340000.0, marking a year-over-year decrease of 18099.17%. This contributed to the annual value of -$340000.0 for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' Revenue is -$75000.0.
- Solid Biosciences' Revenue's 5-year high stood at $6.2 million during Q2 2022, with a 5-year trough of -$121000.0 in Q1 2023.
- Over the past 3 years, Solid Biosciences' median Revenue value was -$85000.0 (recorded in 2024), while the average stood at $951333.3.
- Examining YoY changes over the last 5 years, Solid Biosciences' Revenue showed a top increase of 2148.76% in 2024 and a maximum decrease of 2148.76% in 2024.
- Over the past 3 years, Solid Biosciences' Revenue (Quarter) stood at $6.2 million in 2022, then plummeted by 101.96% to -$121000.0 in 2023, then surged by 38.02% to -$75000.0 in 2024.
- Its last three reported values are -$75000.0 in Q4 2024, -$82000.0 for Q3 2024, and -$88000.0 during Q2 2024.